Status:
COMPLETED
Prospective Assessment of Efficacy and Safety of Drug Eluting Stents
Lead Sponsor:
China National Center for Cardiovascular Diseases
Conditions:
Coronary Heart Disease
Eligibility:
All Genders
18+ years
Brief Summary
Coronary heart disease (CHD) pose a serious health threat to population. PCI using drug eluting stents (DES), as a well-proved and booming measure in CHD management, is invasive and of high cost, howe...
Detailed Description
In this study, 6000 patients who underwent the first-ever drug eluting stents (DES) deployment during the index hospitalization will be consecutively recruited in 30 tertiary hospitals scattered all o...
Eligibility Criteria
Inclusion
- At least one DES is implanted successfully in the procedure
- Only one of the five major brands of DES is used in the procedure
Exclusion
- Prior stent implantation history
Key Trial Info
Start Date :
December 1 2013
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 1 2015
Estimated Enrollment :
6023 Patients enrolled
Trial Details
Trial ID
NCT02313038
Start Date
December 1 2013
End Date
July 1 2015
Last Update
August 31 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Fuwai hospital
Beijing, Beijing Municipality, China, 100037